Maybe if I read it to you, you might understand. Phase 3 is an efficacy test.
Maybe you should learn to use your brain. Phase 3 is the last trial before FDA approval, and this shot does not have FDA approval. You keep spinning the truth here, OK you're lying.
Originally Posted by MM879
Just watch the TV for 15 minutes. You will see and advertisement for a cancer immunization based on similar processes, different targets, different results. There are multiple vaccines FDA approved from similar development processes. The completed process is what allowed pharma to develop a custom vaccine so fast. This is not new to them.
You're clueless.
1 - This isn't a vaccine, so you're lying there. Even the manufs admit it doesn't keep you from becoming infected with the virus. You clowns in the medical industry keep chirping vaccine to brainwash the public into thinking it is safe, because you are branding it as such, a vaccine. Repeat the lie until it becomes truth. That makes you a criminal for pushing a fraudulent statement. 2 - this isn't about cancer, so you put out a strawman argument. 3 - They didn't develop squat. They developed a marketing campaign based on fear and lies, and relying on clowns like you to spread it. You're such a big azzhat clown you refuse to acknowledge it is a phase 3 trial, when doctors everywhere have acknowledged this fact.
Enjoy the read.
Abstract mRNA cancer vaccines are a relatively new class of vaccines, which combine the potential of mRNA to encode for almost any protein with an excellent safety profile and a flexible production process. The most straightforward use of mRNA vaccines in oncologic settings is the immunization of patients with mRNA vaccines encoding tumor-associated antigens (TAAs). This is exemplified by the RNActive® technology, which induces balanced humoral and cellular immune responses in animal models and is currently evaluated in several clinical trials for oncologic indications. A second application of mRNA vaccines is the production of personalized vaccines. This is possible because mRNA vaccines are produced by a generic process, which can be used to quickly produce mRNA vaccines targeting patient-specific neoantigens that are identified by analyzing the tumor exome. Apart from being used directly to vaccinate patients, mRNAs can also be used in cellular therapies to transfect patient-derived cells in vitro and infuse the manipulated cells back into the patient. One such application is the transfection of patient-derived dendritic cells (DCs) with mRNAs encoding TAAs, which leads to the presentation of TAA-derived peptides on the DCs and an activation of antigen-specific T cells in vivo. A second application is the transfection of patient-derived T cells with mRNAs encoding chimeric antigen receptors, which allows the T cells to directly recognize a specific antigen expressed on the tumor. In this chapter, we will review preclinical and clinical data for the different approaches.
ROFLMAO.. You post cancer documentation when the topic is on a Corona virus.
That's called a strawman argument in case you are completely void of brain cells.
You lose.
mRNA has failed in corona virus shot development for 20 years.
Corona virus is the topic, not cancer, clown.
"He is far from Stupid"
”person, who happens to have an above-average level of intelligence”
